A clinically validated whole genome pipeline for structural variant detection and analysis

With the continuing decrease in cost of whole genome sequencing (WGS), we have already approached the point of inflection where WGS testing has become economically feasible, facilitating broader access to the ...

Source: BMC Genomics - July 16, 2019 Category: Genetics & Stem Cells Authors: Nir Neerman, Gregory Faust, Naomi Meeks, Shira Modai, Limor Kalfon, Tzipora Falik-Zaccai and Alexander Kaplun Tags: Research Source Type: research